Patent · US Active

GSK-3 inhibitors

US10752609B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Richard A. Hartz · Kennett Square, US
Vijay T. Ahuja · Middletown, US
Guanglin Luo · Newtown, US
Ling Chen · Shanghai, CN
Prasanna Sivaprakasam · Lawrenceville, US
Gene M. Dubowchik · Middlefield, US
Swanee E. Jacutin-Porte · Madison, US
John E. Macor · Guilford, US

Key dates

Filing date	Nov 27, 2017
Grant date	Aug 25, 2020
Priority date	—
Expiry date	Nov 27, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.